Cargando…
Hemostasis and inflammation: two of a kind?
Hemostasis is a defense mechanism to stop bleeding. Activated by vessel wall injury, it consists of intertwined activation of platelets and the coagulation cascade, tightly controlled by natural anticoagulants and the fibrinolytic system.
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784434/ https://www.ncbi.nlm.nih.gov/pubmed/19922636 http://dx.doi.org/10.1186/1477-9560-7-15 |
| _version_ | 1782174744240455680 |
|---|---|
| author | Verhamme, Peter Hoylaerts, Marc F |
| author_facet | Verhamme, Peter Hoylaerts, Marc F |
| author_sort | Verhamme, Peter |
| collection | PubMed |
| description | Hemostasis is a defense mechanism to stop bleeding. Activated by vessel wall injury, it consists of intertwined activation of platelets and the coagulation cascade, tightly controlled by natural anticoagulants and the fibrinolytic system. |
| format | Text |
| id | pubmed-2784434 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27844342009-11-27 Hemostasis and inflammation: two of a kind? Verhamme, Peter Hoylaerts, Marc F Thromb J Latest therapeutic developments Hemostasis is a defense mechanism to stop bleeding. Activated by vessel wall injury, it consists of intertwined activation of platelets and the coagulation cascade, tightly controlled by natural anticoagulants and the fibrinolytic system. BioMed Central 2009-11-18 /pmc/articles/PMC2784434/ /pubmed/19922636 http://dx.doi.org/10.1186/1477-9560-7-15 Text en Copyright ©2009 Verhamme and Hoylaerts; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Latest therapeutic developments Verhamme, Peter Hoylaerts, Marc F Hemostasis and inflammation: two of a kind? |
| title | Hemostasis and inflammation: two of a kind? |
| title_full | Hemostasis and inflammation: two of a kind? |
| title_fullStr | Hemostasis and inflammation: two of a kind? |
| title_full_unstemmed | Hemostasis and inflammation: two of a kind? |
| title_short | Hemostasis and inflammation: two of a kind? |
| title_sort | hemostasis and inflammation: two of a kind? |
| topic | Latest therapeutic developments |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784434/ https://www.ncbi.nlm.nih.gov/pubmed/19922636 http://dx.doi.org/10.1186/1477-9560-7-15 |
| work_keys_str_mv | AT verhammepeter hemostasisandinflammationtwoofakind AT hoylaertsmarcf hemostasisandinflammationtwoofakind |